MY012 (Mabylon)

N/A

Report date: 2024/09/24 10:22:45

Base Information

Drug NameMY012 (Mabylon)
Drug Alias NameMY012 (Mabylon)MY-012 (Mabylon)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMabylon Ag
China Registration ClassN/A

Develop Information

Active CompaniesMabylon Ag
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A